Antigenics Claims Skin Cancer Advances (AP via Yahoo! News)

Biotech company Antigenics Inc. said Monday that preliminary data from a late-stage clinical trial suggests that its Oncophage cancer vaccine extended the survival of advanced skin cancer patients by about 8 months compared with standard therapies. more...

http://strivectin.good-shopper.com/strivectin.good-shopper.htm